https://www.food.gov.uk/business-guidance/eu-exit-changes-to-health-and-identification-marks<\/a><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-06-11", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-06-11T15:33:20.407Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-06-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Animal Products: Labelling"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the costs which will be accrued as a result of the cost of changing stamps bearing the UK's ISO mark for animal products from EC to GB if the UK leaves the EU.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "258880"}
, {"_about" : "http://data.parliament.uk/resources/1125623", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1125623/answer", "answerText" : {"_value" : "
The Department does not have a standing working group on medicinal cannabis. It has, however, held a number of engagement events with representatives of patients and health professionals in relation to this policy.<\/p>
The National Institute for Health and Care Excellence (NICE) has been commissioned to update and replace interim clinical guidelines on the prescribing of cannabis-based products for medicinal use by October 2019. NICE has consulted with a wide range of stakeholders on the draft scope of the guidelines, including a stakeholder workshop held on 6 November 2018, which was attended by patient and health professional organisations. NICE is expected to issue a public consultation on draft guidelines, which will commence in summer 2019. Anyone interested in this topic, who wants to be involved in the consultation process, can register as a stakeholder at www.nice.org.uk by searching \u201cGID-NG10124\u201d.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-14T15:25:08.807Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) increase public consultation on the creation of interim guidance for medicinal cannabis and (b) ensure patient and health professional organisations are engaged in the Department\u2019s working group on medicinal cannabis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "252465"}
, {"_about" : "http://data.parliament.uk/resources/1125739", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1125739/answer", "answerText" : {"_value" : "
The Department has engaged with patient organisations on multiple occasions as part of the negotiation and implementation of the voluntary scheme. The Department is currently working closely with NHS England and the Association of the British Pharmaceutical Industry to develop success factors for the 2019 voluntary scheme and will keep patient groups informed on progress.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-17", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-17T12:34:07.99Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-05-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has plans to involve patient organisations in setting the success factors for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access as part of the first operational review meeting.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "252468"}
, {"_about" : "http://data.parliament.uk/resources/1123157", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1123157/answer", "answerText" : {"_value" : "
The Department has held a number of engagement events with representatives of patients and health professionals in relation to this policy.<\/p>
The Department has also arranged three meetings with stakeholders, ahead of the National Institute for Health and Care Excellence publishing its guidelines on the prescribing of cannabis-based products for medicinal use in October 2019. These meetings are attended by relevant Government departments, public bodies including advisory committees and professional clinical organisations. The purpose of these meetings is to make sure work, already commissioned to implement policy on medicinal cannabis, continues to align in the interim period before the guidelines are issued.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-05-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-05-03T13:02:14.267Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-04-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patient and health professional organisations are engaged in the Department's working group on medicinal cannabis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"}
}
, "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"}
, "tablingMemberPrinted" : [{"_value" : "Tom Brake"}
], "uin" : "247543"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}